TREATMENT OF HYPERTENSIVE PATIENTS WITH HIGH OR VERY HIGH CARDIOVASCULAR RISK. PHARMACOECONOMIC EFFICIENCY OF A TRIPLE COMBINATION THERAPY CONTAINING ANGIOTENSIN CONVERTING ENZYME INHIBITOR, CALCIUM CHANNEL BLOCKER AND STATIN
Arterial hypertension (AH) is one of the most common cardiovascular diseases and a frequent cause of cardiovascular complications and early disability. In Russia, AH of varying severity may affect about 30% of the population. [1] Hypertension is the causal factor for 27% of cardiovascular events in...
| Main Author: | |
|---|---|
| Format: | Article |
| Language: | Russian |
| Published: |
Remedium Group LLC
2016-12-01
|
| Series: | Медицинский совет |
| Subjects: | |
| Online Access: | https://www.med-sovet.pro/jour/article/view/1353 |
| _version_ | 1827962463209914368 |
|---|---|
| author | I. N. DYAKOV |
| author_facet | I. N. DYAKOV |
| author_sort | I. N. DYAKOV |
| collection | DOAJ |
| description | Arterial hypertension (AH) is one of the most common cardiovascular diseases and a frequent cause of cardiovascular complications and early disability. In Russia, AH of varying severity may affect about 30% of the population. [1] Hypertension is the causal factor for 27% of cardiovascular events in women and 37% in men. [2] AH accounts for about 14% of myocardial infarctions in men and 30% in women [3], 35% of ischemic strokes, 39% of chronic heart failures in men and 59% in women, and 56% of cases of chronic renal disease. [4–6] |
| first_indexed | 2024-04-09T16:43:03Z |
| format | Article |
| id | doaj.art-0442b5c268ba459cb1e7d625ba97c179 |
| institution | Directory Open Access Journal |
| issn | 2079-701X 2658-5790 |
| language | Russian |
| last_indexed | 2024-04-09T16:43:03Z |
| publishDate | 2016-12-01 |
| publisher | Remedium Group LLC |
| record_format | Article |
| series | Медицинский совет |
| spelling | doaj.art-0442b5c268ba459cb1e7d625ba97c1792023-04-23T06:56:36ZrusRemedium Group LLCМедицинский совет2079-701X2658-57902016-12-0101361210.21518/2079-701X-2016-13-6-121351TREATMENT OF HYPERTENSIVE PATIENTS WITH HIGH OR VERY HIGH CARDIOVASCULAR RISK. PHARMACOECONOMIC EFFICIENCY OF A TRIPLE COMBINATION THERAPY CONTAINING ANGIOTENSIN CONVERTING ENZYME INHIBITOR, CALCIUM CHANNEL BLOCKER AND STATINI. N. DYAKOV0I. I. MECHNIKOV Research Institute of Vaccines and Sera, RemediumArterial hypertension (AH) is one of the most common cardiovascular diseases and a frequent cause of cardiovascular complications and early disability. In Russia, AH of varying severity may affect about 30% of the population. [1] Hypertension is the causal factor for 27% of cardiovascular events in women and 37% in men. [2] AH accounts for about 14% of myocardial infarctions in men and 30% in women [3], 35% of ischemic strokes, 39% of chronic heart failures in men and 59% in women, and 56% of cases of chronic renal disease. [4–6]https://www.med-sovet.pro/jour/article/view/1353hypertensionace inhibitorscalcium channel blockersstatinspharmacoeconomic efficiency |
| spellingShingle | I. N. DYAKOV TREATMENT OF HYPERTENSIVE PATIENTS WITH HIGH OR VERY HIGH CARDIOVASCULAR RISK. PHARMACOECONOMIC EFFICIENCY OF A TRIPLE COMBINATION THERAPY CONTAINING ANGIOTENSIN CONVERTING ENZYME INHIBITOR, CALCIUM CHANNEL BLOCKER AND STATIN Медицинский совет hypertension ace inhibitors calcium channel blockers statins pharmacoeconomic efficiency |
| title | TREATMENT OF HYPERTENSIVE PATIENTS WITH HIGH OR VERY HIGH CARDIOVASCULAR RISK. PHARMACOECONOMIC EFFICIENCY OF A TRIPLE COMBINATION THERAPY CONTAINING ANGIOTENSIN CONVERTING ENZYME INHIBITOR, CALCIUM CHANNEL BLOCKER AND STATIN |
| title_full | TREATMENT OF HYPERTENSIVE PATIENTS WITH HIGH OR VERY HIGH CARDIOVASCULAR RISK. PHARMACOECONOMIC EFFICIENCY OF A TRIPLE COMBINATION THERAPY CONTAINING ANGIOTENSIN CONVERTING ENZYME INHIBITOR, CALCIUM CHANNEL BLOCKER AND STATIN |
| title_fullStr | TREATMENT OF HYPERTENSIVE PATIENTS WITH HIGH OR VERY HIGH CARDIOVASCULAR RISK. PHARMACOECONOMIC EFFICIENCY OF A TRIPLE COMBINATION THERAPY CONTAINING ANGIOTENSIN CONVERTING ENZYME INHIBITOR, CALCIUM CHANNEL BLOCKER AND STATIN |
| title_full_unstemmed | TREATMENT OF HYPERTENSIVE PATIENTS WITH HIGH OR VERY HIGH CARDIOVASCULAR RISK. PHARMACOECONOMIC EFFICIENCY OF A TRIPLE COMBINATION THERAPY CONTAINING ANGIOTENSIN CONVERTING ENZYME INHIBITOR, CALCIUM CHANNEL BLOCKER AND STATIN |
| title_short | TREATMENT OF HYPERTENSIVE PATIENTS WITH HIGH OR VERY HIGH CARDIOVASCULAR RISK. PHARMACOECONOMIC EFFICIENCY OF A TRIPLE COMBINATION THERAPY CONTAINING ANGIOTENSIN CONVERTING ENZYME INHIBITOR, CALCIUM CHANNEL BLOCKER AND STATIN |
| title_sort | treatment of hypertensive patients with high or very high cardiovascular risk pharmacoeconomic efficiency of a triple combination therapy containing angiotensin converting enzyme inhibitor calcium channel blocker and statin |
| topic | hypertension ace inhibitors calcium channel blockers statins pharmacoeconomic efficiency |
| url | https://www.med-sovet.pro/jour/article/view/1353 |
| work_keys_str_mv | AT indyakov treatmentofhypertensivepatientswithhighorveryhighcardiovascularriskpharmacoeconomicefficiencyofatriplecombinationtherapycontainingangiotensinconvertingenzymeinhibitorcalciumchannelblockerandstatin |